Correlation of p53 and bcl-2 expression with vascular endothelial growth factor (VEGF), microvessel density (MVD) and clinico-pathological features in colon cancer.
about
Evidence that the p53 negative / Bcl-2 positive phenotype is an independent indicator of good prognosis in colorectal cancer: a tissue microarray study of 460 patients.The association of p53 expression levels with clinicopathological features and prognosis of patients with colon cancer following surgeryAssessment of vascular endothelial growth factor in formalin fixed, paraffin embedded colon cancer specimens by means of a well-based reverse phase protein arrayTumour proliferation, angiogenesis, and ploidy status in human colon cancerCOX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables.The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients.Monitoring tumor response to linifanib therapy with SPECT/CT using the integrin αvβ3-targeted radiotracer 99mTc-3P-RGD2.The clinical value of von Willebrand factor in colorectal carcinomas.Role of CD34, vascular endothelial growth factor, and p53 in neoangiogenesis as correlated with stage of disease in colorectal carcinoma.Expression and heterodimer-binding activity of Ku70 and Ku80 in human non-melanoma skin cancer.Predictive value of vascular endothelial growth factor polymorphisms on the risk of renal cell carcinomas: a case-control study.Relationship between vascular endothelial growth factor and Notch1 expression and lymphatic metastasis in tongue cancer.Inhibition of hemangioma development in a syngeneic mouse model correlates with bcl-2 suppression and the inhibition of Akt kinase activity.Oncosuppressors and Oncogenes: Role in Haemangioma Genesis and Potential for Therapeutic Targeting.Three single nucleotide polymorphisms of the vascular endothelial growth factor (VEGF) gene and glioma risk in a Chinese population.
P2860
Q24815660-FD5AA7E5-544A-4C35-AAE0-D819C4EEC2D1Q33684362-F936D1B3-AF49-441A-A17E-75B22278F98EQ33688120-C64C459C-FA23-4A80-9503-CE0916103BCCQ35588810-BBB76B3C-C891-4B52-B1F6-7E42330388BAQ35769624-D3FB4B90-6016-4F74-A177-93402F46C9ECQ36611554-52391100-30AF-482E-BF31-C3B21EAAE591Q37027027-E73C99BF-2F58-4BB4-B4F1-873281954EC4Q38880592-6C8915F7-1FF5-42C0-9867-86AD8D84D2BDQ41864226-44455D15-A6B8-4936-AB11-407EFBBA1DF9Q42491290-2F72A72B-DCC5-43A6-BBF4-AA36713D0C3CQ50908770-93D28123-B1A2-43A0-80E2-805F3173DE1DQ51747247-10DF0424-1A34-4E41-B86D-8631332DCCC8Q53276939-DBB3A75A-F2DE-4C78-BA3C-8BB5A1B0404FQ53693166-C3B3B402-8F5A-4F0F-8FFD-84D3CAA0983EQ55461490-9ACC72BE-4767-4C3E-81B2-0E970AAD5310
P2860
Correlation of p53 and bcl-2 expression with vascular endothelial growth factor (VEGF), microvessel density (MVD) and clinico-pathological features in colon cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Correlation of p53 and bcl-2 e ...... ical features in colon cancer.
@en
Correlation of p53 and bcl-2 e ...... ical features in colon cancer.
@nl
type
label
Correlation of p53 and bcl-2 e ...... ical features in colon cancer.
@en
Correlation of p53 and bcl-2 e ...... ical features in colon cancer.
@nl
prefLabel
Correlation of p53 and bcl-2 e ...... ical features in colon cancer.
@en
Correlation of p53 and bcl-2 e ...... ical features in colon cancer.
@nl
P2093
P50
P1433
P1476
Correlation of p53 and bcl-2 e ...... gical features in colon cancer
@en
P2093
P304
P356
10.1016/J.CANLET.2003.11.032
P407
P577
2004-05-01T00:00:00Z